Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Antimicrobial Agents and Chemotherapy
|
February 24, 2010
CEM-101 activity against Gram-positive organisms
Leah N Woosley, Mariana Castanheira, Ronald N Jones
The Journal of Antimicrobial Chemotherapy
|
March 23, 2011
Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007-09)
Mariana Castanheira, Rodrigo E Mendes, Leah N Woosley, et al.
Antimicrobial Agents and Chemotherapy
|
October 23, 2013
Retrospective molecular analysis of DIM-1 metallo-β-lactamase discovered in Pseudomonas stutzeri from India in 2000
Lalitagauri M Deshpande, Ronald N Jones, Leah N Woosley, et al.
Microbiology Spectrum
|
January 16, 2023
Performance of the Vitek 2 Advanced Expert System (AES) as a Rapid Tool for Reporting Antimicrobial Susceptibility Testing (AST) in <i>Enterobacterales</i> from North and Latin America
Cecilia G Carvalhaes, Dee Shortridge, Leah N Woosley, et al.
Open Forum Infectious Diseases
|
March 22, 2019
Application of Next-Generation Sequencing for Characterization of Surveillance and Clinical Trial Isolates: Analysis of the Distribution of β-lactamase Resistance Genes and Lineage Background in the United States
Rodrigo E Mendes, Ronald N Jones, Leah N Woosley, et al.
Journal of Clinical Microbiology
|
May 31, 2013
Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance
Michael A Pfaller, Shawn A Messer, Leah N Woosley, et al.
Journal of Clinical Microbiology
|
January 8, 2010
Performance of fusidic acid (CEM-102) susceptibility testing reagents: broth microdilution, disk diffusion, and Etest methods as applied to Staphylococcus aureus
Ronald N Jones, Mariana Castanheira, Paul R Rhomberg, et al.
Mycopathologia
|
May 15, 2012
Significance of molecular identification and antifungal susceptibility of clinically significant yeasts and moulds in a global antifungal surveillance programme
Michael A Pfaller, Leah N Woosley, Shawn A Messer, et al.
Journal of Clinical Microbiology
|
October 27, 2012
Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillance programs
Mariana Castanheira, Leah N Woosley, Daniel J Diekema, et al.
Antimicrobial Agents and Chemotherapy
|
December 21, 2011
Oritavancin activity against vancomycin-susceptible and vancomycin-resistant Enterococci with molecularly characterized glycopeptide resistance genes recovered from bacteremic patients, 2009-2010
Rodrigo E Mendes, Leah N Woosley, David J Farrell, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Antimicrobial Agents and Chemotherapy
|
February 24, 2010
CEM-101 activity against Gram-positive organisms
Leah N Woosley, Mariana Castanheira, Ronald N Jones
The Journal of Antimicrobial Chemotherapy
|
March 23, 2011
Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007-09)
Mariana Castanheira, Rodrigo E Mendes, Leah N Woosley, et al.
Antimicrobial Agents and Chemotherapy
|
October 23, 2013
Retrospective molecular analysis of DIM-1 metallo-β-lactamase discovered in Pseudomonas stutzeri from India in 2000
Lalitagauri M Deshpande, Ronald N Jones, Leah N Woosley, et al.
Microbiology Spectrum
|
January 16, 2023
Performance of the Vitek 2 Advanced Expert System (AES) as a Rapid Tool for Reporting Antimicrobial Susceptibility Testing (AST) in <i>Enterobacterales</i> from North and Latin America
Cecilia G Carvalhaes, Dee Shortridge, Leah N Woosley, et al.
Open Forum Infectious Diseases
|
March 22, 2019
Application of Next-Generation Sequencing for Characterization of Surveillance and Clinical Trial Isolates: Analysis of the Distribution of β-lactamase Resistance Genes and Lineage Background in the United States
Rodrigo E Mendes, Ronald N Jones, Leah N Woosley, et al.
Journal of Clinical Microbiology
|
May 31, 2013
Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance
Michael A Pfaller, Shawn A Messer, Leah N Woosley, et al.
Journal of Clinical Microbiology
|
January 8, 2010
Performance of fusidic acid (CEM-102) susceptibility testing reagents: broth microdilution, disk diffusion, and Etest methods as applied to Staphylococcus aureus
Ronald N Jones, Mariana Castanheira, Paul R Rhomberg, et al.
Mycopathologia
|
May 15, 2012
Significance of molecular identification and antifungal susceptibility of clinically significant yeasts and moulds in a global antifungal surveillance programme
Michael A Pfaller, Leah N Woosley, Shawn A Messer, et al.
Journal of Clinical Microbiology
|
October 27, 2012
Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillance programs
Mariana Castanheira, Leah N Woosley, Daniel J Diekema, et al.
Antimicrobial Agents and Chemotherapy
|
December 21, 2011
Oritavancin activity against vancomycin-susceptible and vancomycin-resistant Enterococci with molecularly characterized glycopeptide resistance genes recovered from bacteremic patients, 2009-2010
Rodrigo E Mendes, Leah N Woosley, David J Farrell, et al.
Page
of 2